“EY Biotech beyond borders” conference ⎟22 sept.-15 @ Campus Biotech ⎟last call

“EY Biotech beyond borders” conference ⎟22 sept.-15 @ Campus Biotech ⎟last call

 

Learn from Leading executives:

PROGRAM:

Part 1:
Release of the EY Biotech Report beyond borders 2015,

by Jürg Zürcher (EY)

The global biotech industry scaled new heights in 2014 and broke existing records for profits, sales, funding and research expenditure. In a report named Beyond borders: Reaching new heights published today by auditing and consulting company EY, the authors state that as a consequence of this growth, successful new treatments and the increased number of regulatory approvals for new drugs, the market capitalization of the entire industry reached a record USD 1,063 trillion.

Part 2:

Swiss Innovation Park: All you need to know – How does it benefit you?

by M Philippe Leyvraz (Director of the Swiss Innovation Park West)

The Swiss Innovation Park aims at developing innovative ideas into marketable products and offering domestic and foreign companies the best locations: first class accessibility, close to universities, suitable for further expansion, and in attractive locations. Learn more from its director.

Part 3:

Round table discussion involving industry leaders:

  • International Federation of Pharmaceutical Manufacturers & Associations, Dr Brendan Shaw (Assistant Director General)
  • Addex Therapeutics, Tim Dyer (CEO)
  • Altran, Florent Saillard (Lifescience Director)
  • Merck Serono, Jens Regelin (VP, Site Director)

 

Part 4:

Networking Apero

 

Do not miss an exceptional opportunity and attend this event on Tuesdy 22nd 2015 – 17:00 :

Free entrance upon registration

REGISTER

(C-Suite website)

 

 

Nextrends series:

As the business world becomes increasingly complex, so do the challenges facing today’s senior business leaders. And although CEOs, CMOs, CIOs, CFOs and CHROs agree that complexity is at an all-time high, they have differing views on what’s driving it, and, more important, how to address it.

Leading executives will be on hand to discuss cutting-edge business challenges currently facing the Life Sciences industry which include topics such as the drivers of change, global business challenges, translation of innovation, innovation strategies.

Leave a reply